Biological Effects of p62 siRNA on Hepatoma Cell Hep3B

LUO Xiaoyang,WU Bolin,HU Guimei,LUO Zhongjin,GUO Wuhua,ZHANG Jixiang
DOI: https://doi.org/10.3969/j.issn.0253-9896.2010.06.001
2010-01-01
Abstract:Objective: To investigate the biological effects of p62 siRNA on hepatoma cell Hep3B. Methods: Three siRNA sequences, specifically targeting p62 (named as Si-h-GTF2H1_001, Si-h-GTF2H1_002 and Si-h-GTF2H1_003), were selected. The one of silent p62 was Si-h-GTF2H1_002. The siRNAs were transfected into hepatoma cell Hep3B with Lipofectamine 2000. There were four groups in this study including blank control group, siRNA group, Ncontrol (NC)group and Lipofectamine (Lip) group. The expressions of p62, XPD, p53 and cyclinD1 were detected by RT-PCR and Western blot. The cell cycle was examined by MTT. Results: Compared with blank control group, NC group and Lip group, the expressions of p62, XPD and p53 mRNA decreased significantly in siRNA group (P < 0.01); but the expressions of cyclinD1 mRNA was enhanced obviously in siRNA group(P < 0.01). The trends of p62, XPD, p53 and cyclinD1 protein were consistent with trend of mRNA detected by Western blot. MTT results showed that cell proliferation increased in siRNA group. Conclusion: p62 gene may inhibit cancer cells by interacting with XPD, p53 and cyclinD1, and possibly regulate cell proliferation through DNA damage checkpoint.
What problem does this paper attempt to address?